HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom G Caniels Selected Research

Neutralizing Antibodies

1/2022A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
10/2020An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain.
7/2020An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain.
1/2020Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom G Caniels Research Topics

Disease

17COVID-19
11/2023 - 01/2020
7Infections
10/2023 - 01/2021
2Inflammation (Inflammations)
11/2023 - 01/2021
2Thrombosis (Thrombus)
11/2023 - 01/2021
1Human Influenza (Influenza)
01/2022
1Lymphopenia (Lymphocytopenia)
10/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Critical Illness (Critically Ill)
01/2021

Drug/Important Bio-Agent (IBA)

9VaccinesIBA
10/2023 - 01/2020
8AntibodiesIBA
11/2023 - 01/2020
5Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2020
4Neutralizing AntibodiesIBA
01/2022 - 01/2020
3Immunoglobulin G (IgG)IBA
11/2023 - 01/2021
2AntigensIBA
10/2023 - 10/2022
2Glycoproteins (Glycoprotein)IBA
10/2023 - 10/2022
2BNT162 VaccineIBA
01/2022 - 01/2021
16- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA
11/2023
1Antiviral Agents (Antivirals)IBA
11/2023
1N-Acetylneuraminic Acid (Sialic Acid)IBA
10/2022
1Hemagglutinins (Hemagglutinin)IBA
01/2022
1mRNA VaccinesIBA
01/2022
1COVA1-18IBA
10/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1NanovaccinesIBA
01/2021
1Monoclonal AntibodiesIBA
01/2020

Therapy/Procedure

1Therapeutics
11/2023